APOEε4 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

82 results for “APOEε4”

Trials

View all 54 →

Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD

200 participants · First posted Aug 26, 2014

Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease

50 participants · First posted Dec 14, 2022

Plasmapheresis Versus Plasma Infusion from Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression

3 participants · First posted Mar 25, 2019

Drugs

ApoE4 (ICBI)

C-terminal-ApoE4 (ICBI)

APOE4 gene-targeting small molecules

News

View all 20 →

Antibody Fragment Eliminates Brain Haemorrhage Risk in Alzheimer's Immunotherapy, Preclinical Study Shows

Early Lecanemab Treatment Shows Sustained Benefits in Alzheimer's Disease

Lecanemab Shows Long-Term Benefits in Early Alzheimer's Disease, Eisai Data Shows

Page 1 of 9